p53 protein accumulation and gene mutations in human glioma cell lines

International Journal of Cancer

Volumn 55, Issue 6, 1993, Pages 982-987

  Anker, Lars ^a   Ohgaki, Hiroko ^b   Ludeke, Barbara I ^b   Herrmann, Hans‐Dietrich ^a   Kleihues, Paul ^b   Westphal, Manfred ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; TUMOR CELL LINE;

BASE SEQUENCE; BLOTTING, WESTERN; CHROMOSOME DELETION; CODON; EXONS; FEMALE; GENES, P53; GLIOMA; HUMAN; MALE; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRECIPITIN TESTS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0027331499     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910550618     Document Type: Article

References (32)

1. p53 abnormalities in different subtypes of human sarcomas
2. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood
3. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas
4. Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro
5. Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency
6. The mutational spectrum of single base‐pair substitutions causing human genetic desease: patterns and predictions
7. Molecular basis of base substitution hotspots in Escherichia coil
8. Association of polyomaviruses JC, SV40, and BK with human brain tumors
9. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
10. p53 immunostaining as a marker of malignant disease in diagnostic cytopathology
11. Proto‐oncogene expression in human glioma derived cell lines
12. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53
13. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts
14. p53 mutations in human cancers
15. p53 mutations are absent from carcinogeninduced mouse liver tumors but occur in cell lines established from these tumors
16. p53, guardian of the genome
17. The p53 tumour suppressor gene and product
18. Characterization of a 54Kdalton cellular SV40 tumor antigen present in SV40‐transformed cells and uninfected embryonal carcinoma cells
19. Comparative study of p53 gene and protein alteration in human astrocytic tumors
20. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
21. Cotranslation of activated mutant p53 with wild type drives the wild‐type p53 protein into the mutant conformation
22. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
23. A comparative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
24. Mutations in the p53 gene occur in diverse human tumour types
25. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
26. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17p distinct from p53 in malignant astrocytomas
27. Clonal expansion of p53 mutant cells is associated with brain tumour progression
28. p53 function and dysfunction
29. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas
30. Association of human papillomavirus types 16 and 18 E6 proteins with p53
31. Initiation of primary cell cultures from human intracranial tumors on extracellular matrix from bovine corneal endothelial cells